MedPath

An online lifestyle intervention to improve cognition of cancer patients

Recruiting
Conditions
cancer-related cognitive impairment
chemobrain
10009841
Registration Number
NL-OMON50422
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
230
Inclusion Criteria

* Having received chemotherapy treatment for any recently diagnosed non-CNS
cancer
* Chemotherapy treatment has been completed
* Presence of cognitive complaints
* ><= 18 years of age
* Written informed consent

Exclusion Criteria

* Primary or secondary brain tumours
* Insufficient mastery of the Dutch language
* History of brain injury with loss of consciousness
* History of brain surgery
* Currently under active treatment for psychiatric disorders
* Neurodegenerative disorders
* Self-reported substance abuse
* Severe visual impairments

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Feasibility study:<br /><br>Compliance rate of the participants after 3 months, if there is a compliance of<br /><br>more than 50% after 3 months and the feedback from the structured interview is<br /><br>mostly positive we will continue with the main study.<br /><br><br /><br>Main study:<br /><br>The change in subjective cognitive functioning between baseline and 6 months<br /><br>later, comparing the effect of MFB to no intervention. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Feasibility study:<br /><br>Usability<br /><br>Areas of improvement<br /><br><br /><br>Main study:<br /><br>The change in objective cognitive functioning between baseline and 6 months.<br /><br>The change in lifestyle functions between baseline and 6 months.<br /><br>The influence of other parameters such as level of education, work performance,<br /><br>self-efficacy, type of cancer, type of treatment, age, gender, psychological<br /><br>functioning on the effect of the intervention. </p><br>
© Copyright 2025. All Rights Reserved by MedPath